• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Skeletal metastasis from occult carcinoma.

作者信息

Shih L Y, Chen T H, Lo W H

机构信息

Department of Orthopedics and Traumatology, Veterans General Hospital-Taipei, Taiwan, Republic of China.

出版信息

J Surg Oncol. 1992 Oct;51(2):109-13. doi: 10.1002/jso.2930510209.

DOI:10.1002/jso.2930510209
PMID:1405649
Abstract

We reviewed 177 patients with skeletal metastases, seen between 1984 and 1989, to define the characteristics of metastatic bone disease from an occult primary carcinoma. In 52 (30%) patients, the primary carcinomas could not be identified when the bone metastases were first diagnosed. This group was predominantly male, with intractable pain the most common symptom. The primary tumors were identified on antemortem evaluation in 28 (54%) patients after extensive examination. Among these, the primary tumor was in the lung in 9 patients, followed by liver (8), kidney (5), prostate (3), thyroid gland (2), and rectum (1). The identifiable occult malignancies possessed three common features: all were osteophilic tumors, all had a high incidence in the specific geographic area, and all were not amenable to early detection. The mean survival of these patients was 11 months. Current treatment modalities failed to affect the course of these patients, except for those with primary carcinomas of the kidney and prostate. This observation attests to our limitations in both the diagnosis and treatment of this problem. Efforts should be directed primarily toward excluding those common and/or treatable tumors only.

摘要

相似文献

1
Skeletal metastasis from occult carcinoma.
J Surg Oncol. 1992 Oct;51(2):109-13. doi: 10.1002/jso.2930510209.
2
Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.确定原发癌部位不明的骨转移患者的原发癌部位:一项回顾性研究。
Cancer. 1999 Aug 1;86(3):533-7. doi: 10.1002/(sici)1097-0142(19990801)86:3<533::aid-cncr24>3.0.co;2-1.
3
Metastatic bone disease from occult carcinoma: a profile.隐匿性癌所致转移性骨病:概况
Int Orthop. 1989;13(2):119-23. doi: 10.1007/BF00266372.
4
[Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].[经病理确诊的转移性骨肿瘤的临床特征——附390例报告]
Ai Zheng. 2005 Nov;24(11):1404-7.
5
[A clinical evaluation of distant metastases from a hepatocellular carcinoma with reference to location, frequency, symptoms, treatment & prognosis].
Gan No Rinsho. 1990 Sep;36(11):2012-6.
6
Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.不明来源的骨转移瘤。一项诊断策略的前瞻性研究。
J Bone Joint Surg Am. 1993 Sep;75(9):1276-81. doi: 10.2106/00004623-199309000-00003.
7
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.识别神经内分泌肿瘤患者骨转移管理中的改进领域。
Neuroendocrinology. 2020;110(7-8):688-696. doi: 10.1159/000504256. Epub 2019 Oct 22.
8
Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.不明原发灶的骨转移瘤:29例回顾性分析
Acta Orthop Belg. 1997 Mar;63(1):15-22.
9
Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.肾透明细胞肉瘤:发展中国家患者的特征及预后改善
Pediatr Blood Cancer. 2014 Dec;61(12):2185-90. doi: 10.1002/pbc.25192. Epub 2014 Aug 31.
10
Survival of brain metastatic patients in Yazd, Iran.伊朗亚兹德脑转移患者的生存率。
Asian Pac J Cancer Prev. 2014;15(8):3571-4. doi: 10.7314/apjcp.2014.15.8.3571.

引用本文的文献

1
Autopsy-Confirmed Undifferentiated Carcinoma of the Liver With Rapid Bone Metastasis.尸检确诊的伴有快速骨转移的未分化肝癌
Cureus. 2023 Dec 2;15(12):e49848. doi: 10.7759/cureus.49848. eCollection 2023 Dec.
2
Predicting survival of patients with bone metastasis of unknown origin.预测不明来源骨转移患者的生存情况。
Front Endocrinol (Lausanne). 2023 Nov 6;14:1193318. doi: 10.3389/fendo.2023.1193318. eCollection 2023.
3
Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical classifications for bone metastasis of unknown primary (BMUP).
基于数据非依赖采集-质谱(DIA-MS)的骨转移性癌症综合分析揭示了分子指纹,以协助对未知原发灶骨转移(BMUP)进行临床分类。
Transl Cancer Res. 2020 Apr;9(4):2390-2401. doi: 10.21037/tcr.2020.03.41.
4
Squamous Cell Carcinoma of Unknown Primary: Multiple Skeletal Metastases Without Detectable Visceral Lesions.原发灶不明的鳞状细胞癌:多发骨转移且无可见内脏病变。
Cureus. 2021 Jul 20;13(7):e16525. doi: 10.7759/cureus.16525. eCollection 2021 Jul.
5
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview.原发灶不明的骨转移:生物学特征与临床概述
Cancers (Basel). 2019 Aug 29;11(9):1270. doi: 10.3390/cancers11091270.
6
Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.初诊时原发灶不明的骨转移:286例回顾性分析
PLoS One. 2015 Jun 26;10(6):e0129428. doi: 10.1371/journal.pone.0129428. eCollection 2015.
7
Bone metastases of unknown origin: epidemiology and principles of management.原发灶不明的骨转移瘤:流行病学与治疗原则
J Orthop Traumatol. 2015 Jun;16(2):81-6. doi: 10.1007/s10195-015-0344-0. Epub 2015 Mar 1.
8
Spinal pain due to metastasis of unknown origin.不明来源转移所致的脊柱疼痛。
Rheumatol Int. 2005 Sep;25(7):562-4. doi: 10.1007/s00296-004-0575-5. Epub 2005 Feb 2.